Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China
· Delayed Price · Currency is CNY 15.08
-0.24 (-1.57%)
Apr 28, 2025, 2:45 PM CST
Shinva Medical Instrument Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 10,010 | 9,904 | 9,072 | 9,343 | 8,994 | 8,619 | Upgrade
|
| Other Revenue | 108 | 108 | 210.16 | 139.3 | 156.93 | 147.51 | Upgrade
|
| Revenue | 10,118 | 10,012 | 9,282 | 9,482 | 9,151 | 8,767 | Upgrade
|
| Revenue Growth (YoY) | 1.71% | 7.87% | -2.11% | 3.62% | 4.38% | -14.75% | Upgrade
|
| Cost of Revenue | 7,483 | 7,305 | 6,863 | 7,200 | 7,088 | 6,929 | Upgrade
|
| Gross Profit | 2,635 | 2,707 | 2,419 | 2,282 | 2,063 | 1,837 | Upgrade
|
| Selling, General & Admin | 1,348 | 1,433 | 1,349 | 1,324 | 1,300 | 1,345 | Upgrade
|
| Research & Development | 449.19 | 443.37 | 401.27 | 295.98 | 197.53 | 164.08 | Upgrade
|
| Other Operating Expenses | 37.36 | 76.99 | 67.62 | 59.36 | 13.13 | 56.25 | Upgrade
|
| Operating Expenses | 1,922 | 2,037 | 1,846 | 1,714 | 1,593 | 1,640 | Upgrade
|
| Operating Income | 712.65 | 670.31 | 572.27 | 567.33 | 470.58 | 197.32 | Upgrade
|
| Interest Expense | -41.07 | -47.07 | -56.93 | -76.26 | -121.45 | -171.76 | Upgrade
|
| Interest & Investment Income | 107.3 | 110.96 | 61.75 | 126.94 | 58.98 | 1,066 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.54 | 7.54 | 10.37 | -0.99 | -5.48 | 3.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -15.23 | -9.44 | -4.17 | -12.03 | -24.24 | -9.57 | Upgrade
|
| EBT Excluding Unusual Items | 771.19 | 732.3 | 583.29 | 604.99 | 378.39 | 1,086 | Upgrade
|
| Impairment of Goodwill | -11.49 | -11.49 | - | - | -21.67 | -20.35 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.53 | 12.54 | -57.21 | 60.71 | -0.17 | 0.94 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.51 | 4.4 | 0.48 | -0.35 | -3.73 | 10.06 | Upgrade
|
| Asset Writedown | 3.86 | -0.73 | - | -0.62 | - | -8.62 | Upgrade
|
| Legal Settlements | - | - | - | -0.57 | -10.65 | - | Upgrade
|
| Other Unusual Items | 1.57 | 1.57 | 49.53 | 53.87 | 3.13 | 52.88 | Upgrade
|
| Pretax Income | 771.16 | 738.58 | 576.09 | 718.03 | 345.3 | 1,121 | Upgrade
|
| Income Tax Expense | 66.49 | 62.08 | 49.18 | 162.01 | 105.9 | 260.54 | Upgrade
|
| Earnings From Continuing Operations | 704.67 | 676.5 | 526.91 | 556.02 | 239.4 | 860.09 | Upgrade
|
| Minority Interest in Earnings | -12.33 | -22.5 | -26.84 | 0.47 | -5.26 | 1.23 | Upgrade
|
| Net Income | 692.34 | 654 | 500.07 | 556.49 | 234.14 | 861.31 | Upgrade
|
| Net Income to Common | 692.34 | 654 | 500.07 | 556.49 | 234.14 | 861.31 | Upgrade
|
| Net Income Growth | 5.09% | 30.78% | -10.14% | 137.68% | -72.82% | 3680.32% | Upgrade
|
| Shares Outstanding (Basic) | 553 | 595 | 529 | 528 | 525 | 528 | Upgrade
|
| Shares Outstanding (Diluted) | 553 | 595 | 529 | 528 | 525 | 528 | Upgrade
|
| Shares Change (YoY) | -2.76% | 12.50% | 0.08% | 0.64% | -0.65% | 7.09% | Upgrade
|
| EPS (Basic) | 1.25 | 1.10 | 0.95 | 1.05 | 0.45 | 1.63 | Upgrade
|
| EPS (Diluted) | 1.25 | 1.10 | 0.95 | 1.05 | 0.45 | 1.63 | Upgrade
|
| EPS Growth | 8.07% | 16.25% | -10.21% | 136.17% | -72.64% | 3429.87% | Upgrade
|
| Free Cash Flow | 328.99 | 494.34 | 140.47 | 1,128 | 906.78 | 415.13 | Upgrade
|
| Free Cash Flow Per Share | 0.59 | 0.83 | 0.27 | 2.14 | 1.73 | 0.79 | Upgrade
|
| Dividend Per Share | 0.385 | 0.385 | 0.115 | 0.115 | 0.077 | 0.077 | Upgrade
|
| Dividend Growth | 233.28% | 233.28% | - | 50.07% | - | 122.25% | Upgrade
|
| Gross Margin | 26.04% | 27.04% | 26.06% | 24.06% | 22.55% | 20.96% | Upgrade
|
| Operating Margin | 7.04% | 6.69% | 6.17% | 5.98% | 5.14% | 2.25% | Upgrade
|
| Profit Margin | 6.84% | 6.53% | 5.39% | 5.87% | 2.56% | 9.83% | Upgrade
|
| Free Cash Flow Margin | 3.25% | 4.94% | 1.51% | 11.90% | 9.91% | 4.74% | Upgrade
|
| EBITDA | 888.39 | 851.83 | 761.5 | 744.07 | 649.17 | 384.37 | Upgrade
|
| EBITDA Margin | 8.78% | 8.51% | 8.20% | 7.85% | 7.09% | 4.38% | Upgrade
|
| D&A For EBITDA | 175.74 | 181.52 | 189.23 | 176.74 | 178.6 | 187.05 | Upgrade
|
| EBIT | 712.65 | 670.31 | 572.27 | 567.33 | 470.58 | 197.32 | Upgrade
|
| EBIT Margin | 7.04% | 6.69% | 6.17% | 5.98% | 5.14% | 2.25% | Upgrade
|
| Effective Tax Rate | 8.62% | 8.40% | 8.54% | 22.56% | 30.67% | 23.25% | Upgrade
|
| Revenue as Reported | 10,118 | 10,012 | 9,282 | 9,482 | 9,151 | 8,767 | Upgrade
|
| Advertising Expenses | - | 24.19 | 22.66 | 38.05 | 31.12 | 48.99 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.